Boothbay Fund Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,006
Closed -$216K 2062
2025
Q2
$216K Sell
5,006
-31,575
-86% -$1.22M ﹤0.01% 1222
2025
Q1
$1.45M Sell
36,581
-13,525
-27% -$599K 0.04% 510
2024
Q4
$2.04M Buy
50,106
+1,501
+3% +$62.5K 0.05% 442
2024
Q3
$1.9M Buy
+48,605
New +$1.94M 0.04% 535
2020
Q3
Sell
-4,355
Closed -$229K 1150
2020
Q2
$229K Sell
4,355
-6,202
-59% -$294K 0.02% 771
2020
Q1
$372K Buy
+10,557
New +$617K 0.03% 513
2018
Q2
Sell
-4,444
Closed -$327K 849
2018
Q1
$327K Buy
+4,444
New +$332K 0.04% 446
2017
Q4
Sell
-3,462
Closed -$216K 780
2017
Q3
$216K Sell
3,462
-3,400
-50% -$201K 0.04% 486
2017
Q2
$394K Buy
+6,862
New +$404K 0.08% 326
2017
Q1
Sell
-4,662
Closed -$256 889
2016
Q4
$256 Buy
+4,662
New +$224K 0.06% 475

Other funds holding NGVT

Boothbay Fund Management's NGVT Position: Q3 2025 in Review

Boothbay Fund Management sold out of Ingevity (NGVT) in Q3 2025, closing a stake of 5,006 shares — an estimated $216K sold.

Boothbay Fund Management first reported a position in NGVT in Q4 2016 and held it in 10 quarters. The position peaked at $2.04M in Q4 2024. 298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.

  • Boothbay Fund Management reported no remaining Ingevity position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 5,006 Ingevity shares in Q3 2025, an estimated $216K.
  • Boothbay Fund Management first reported a position in Ingevity in Q4 2016 and held it in 10 quarters.
  • Boothbay Fund Management's Ingevity position peaked at $2.04M in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.